Gene therapy in Duchenne muscular dystrophy
- 31 October 1996
- journal article
- review article
- Published by Elsevier in Brain & Development
- Vol. 18 (5) , 357-361
- https://doi.org/10.1016/0387-7604(96)00043-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicityNature, 1993
- HUMAN GENE THERAPYAnnual Review of Biochemistry, 1993
- Human gene therapy comes of ageNature, 1992
- Human dystrophin expression corrects the myopathic phenotype in transgenic mdx miceHuman Molecular Genetics, 1992
- Invited review: Myoblast transfer: A possible therapy for inherited myopathies?Muscle & Nerve, 1991
- Detection of 98% of DMD/BMD gene deletions by polymerase chain reactionHuman Genetics, 1990
- Molecular genetics of Duchenne and Becker muscular dystrophyThe Journal of Pediatrics, 1990
- Very mild muscular dystrophy associated with the deletion of 46% of dystrophinNature, 1990
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987